These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30861618)

  • 1. Identification of compounds that inhibit the binding of Keap1a/Keap1b Kelch DGR domain with Nrf2 ETGE/DLG motifs in zebrafish.
    Raghunath A; Nagarajan R; Sundarraj K; Palanisamy K; Perumal E
    Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):259-270. PubMed ID: 30861618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of keap1a- and keap1b-knockout zebrafish.
    Nguyen VT; Bian L; Tamaoki J; Otsubo S; Muratani M; Kawahara A; Kobayashi M
    Redox Biol; 2020 Sep; 36():101667. PubMed ID: 32828016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic hyperactivation of Nrf2 causes larval lethality in Keap1a and Keap1b-double-knockout zebrafish.
    Bian L; Nguyen VT; Tamaoki J; Endo Y; Dong G; Sato A; Kobayashi M
    Redox Biol; 2023 Jun; 62():102673. PubMed ID: 36934645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular evolution of Keap1. Two Keap1 molecules with distinctive intervening region structures are conserved among fish.
    Li L; Kobayashi M; Kaneko H; Nakajima-Takagi Y; Nakayama Y; Yamamoto M
    J Biol Chem; 2008 Feb; 283(6):3248-3255. PubMed ID: 18057000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
    Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
    Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chromatin-remodeling enzyme Smarca5 regulates erythrocyte aggregation via Keap1-Nrf2 signaling.
    Ding Y; Li Y; Zhao Z; Cliff Zhang Q; Liu F
    Elife; 2021 Oct; 10():. PubMed ID: 34698638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shinorine ameliorates chromium induced toxicity in zebrafish hepatocytes through the facultative activation of Nrf2-Keap1-ARE pathway.
    Shaw P; Sen A; Mondal P; Dey Bhowmik A; Rath J; Chattopadhyay A
    Aquat Toxicol; 2020 Nov; 228():105622. PubMed ID: 32947073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Keap1-Nrf2 small-molecule inhibitors from phytochemicals based on molecular docking.
    Li M; Huang W; Jie F; Wang M; Zhong Y; Chen Q; Lu B
    Food Chem Toxicol; 2019 Nov; 133():110758. PubMed ID: 31412289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Nrf2/Keap1 pathway and its transcriptional regulation of antioxidant genes after exposure to microcystins in freshwater mussel Cristaria plicata.
    Wu J; Liu W; Hou S; Wang Y; Fang H; Luo S; Yang L; Wen C
    Dev Comp Immunol; 2023 Apr; 141():104629. PubMed ID: 36587710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system.
    Kobayashi M; Itoh K; Suzuki T; Osanai H; Nishikawa K; Katoh Y; Takagi Y; Yamamoto M
    Genes Cells; 2002 Aug; 7(8):807-20. PubMed ID: 12167159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular mechanism of Nrf2-Keap1 signaling pathway in the antioxidant defense response induced by BaP in the scallop Chlamys farreri.
    Wang H; Pan L; Xu R; Si L; Zhang X
    Fish Shellfish Immunol; 2019 Sep; 92():489-499. PubMed ID: 31220575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis.
    Jiang ZY; Lu MC; Xu LL; Yang TT; Xi MY; Xu XL; Guo XK; Zhang XJ; You QD; Sun HP
    J Med Chem; 2014 Mar; 57(6):2736-45. PubMed ID: 24512214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
    Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
    Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol targeting NRF2 disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage in mice pulmonary infection.
    Chi F; Cheng C; Zhang M; Su B; Hou Y; Bai G
    J Ethnopharmacol; 2024 Oct; 332():118353. PubMed ID: 38762209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge & Latch mechanism.
    Horie Y; Suzuki T; Inoue J; Iso T; Wells G; Moore TW; Mizushima T; Dinkova-Kostova AT; Kasai T; Kamei T; Koshiba S; Yamamoto M
    Commun Biol; 2021 May; 4(1):576. PubMed ID: 33990683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside CK targeting KEAP1-DGR/Kelch domain disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage.
    Cheng C; Zhang J; Liu K; Xu Y; Shen F; Han Y; Hou Y; Zhang T; Bai G
    Phytomedicine; 2023 Oct; 119():154992. PubMed ID: 37499433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases.
    Pallesen JS; Tran KT; Bach A
    J Med Chem; 2018 Sep; 61(18):8088-8103. PubMed ID: 29750408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an enzyme-linked immunosorbent assay for Keap1-Nrf2 interaction inhibitors identification.
    Wang Y; Xiao CY; Lin HQ; Hu JS; Ip TM; Chi-Cheong Wan D
    Redox Biol; 2020 Jul; 34():101573. PubMed ID: 32422542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel diterpenoid-type activators of the Keap1/Nrf2/ARE signaling pathway and their regulation of redox homeostasis.
    Li AL; Shen T; Wang T; Zhou MX; Wang B; Song JT; Zhang PL; Wang XL; Ren DM; Lou HX; Wang XN
    Free Radic Biol Med; 2019 Sep; 141():21-33. PubMed ID: 31167117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular recognition between potential natural inhibitors of the Keap1-Nrf2 complex.
    Bello M; Morales-González JA
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):981-992. PubMed ID: 28746889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.